EuroNanoBio aims at defining the key features of the future EU capacity in nanobiotechnology and the roadmap to reach this goal. It will establish the features of the infrastructure, the role of the various stakeholders and the way to establish it. This Support Action is divided into three phases: 1) An analytical phase where the existing data, published or not, will be scrutinised and analysed to extract some success factors to be used for defining the EU infrastructure in nanobiotechnology. This analysis is conducted in four directions • existing top class infrastructures or clusters inside and outside Europe • modes of technology transfer from research to industry • multidisciplinary education and training • ancillary aspects of nanobiotechnology. 2) A building and consensus phase where many diverse stakeholders who play a role in the EU capacity in nanobiotechnology are invited to jointly defined and adopt the key features of the infrastructure, and the way to build it 3) A dissemination phase where the former results will be widely disseminated using Internet and a large dissemination event. The EuroNanoBio partners are highly experienced in EU integration in nanobiotechnology in general as well as in specific aspects studied in the CSA. They have unrivalled access to a wide panel of stakeholders in governments, industry, education, regulation, ethics. The consortium will act as a catalyst for these stakeholders to collect their contribution and make them build together the roadmap for establishing the EU capacity in nanobiotechnology.